Advisory Board August 31, 2023
Earlier this week, CMS selected the first 10 drugs that will be subject to Medicare drug price negotiation, with negotiated prices taking effect in 2026. Our analysis estimates the savings that this program would generate if implemented in its current form.
How we modeled the impact
CMS recently published the total Part D gross covered prescription drug costs from June 2022 to May 2023 for the 10 drugs selected for negotiation. We used this data, along with information on when these drugs were first approved, to analyze the...